The G357S mutation decreases both activation and termination thresholds for SOICR. by Yingjie Liu (317210)

PM treatment decreased murine BMSCs level without induction of apoptosis. by Yuqi Cui (736228)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

Bim knockdown decreased sensitivity of C42Luc cells to apoptosis. by Dana Yancey (454370)

siRNA Knockdown of PKCδ decreases phosphorylation of VEEV capsid. by Brian D. Carey (6092747)

Downregulation of CHOP decreases apoptosis by activation of ER stress-induced autophagy. by Yan Lei (535846)

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

PMC exhibits less sensitivity to decreasing signal-to-noise ratio (SNR) by Owen Puls (22340344)

Rank importance, where impairment at a point has a significant association with decreased vision-related quality of life. by Hiroshi Murata (387321)

Quantile trend of <i>τ</i> = 0.1, 0.5 and 0.9 for all 72 stations during the study period. by Qibin Duan (8988614)

Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes by Yoshiko Horie (4923043)

Stress-time curve of the impact test without a rock sample. by Chun Wang (337817)

Temporal changes in the RPR titer from before to after treatment. by Kazuhiko Ikeuchi (9234268)

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1α in <em>ob/ob</em> Mice by Neira Sáinz (260167)

Decreased S100A9 expression alleviates Clostridium perfringens beta2 toxin-induced inflammatory injury in IPEC-J2 cells by Jie Li (13877648)

Suppression of APN/CD13 expression by siRNA induced a marked decrease in migratory potential of ES-2 cells by Mikio Terauchi (35139)

Study selection criteria. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PRISMA flow chart. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”